TAA expression in patients with AML (n = 116): correlation with clinical parameters
. | BCL2 . | CA9 . | HMMR . | LAMR1 . | PRAME . | PRTN3 . | TERT . | WT1 . | No vs at least 1 TAA . |
|---|---|---|---|---|---|---|---|---|---|
| Older than 60 y, P | NS | NS | NS | NS | NS | NS | NS | NS | <.001 |
| WBC count below 30 × 109/L, P | NS | NS | .027 | .002 | NS | NS | NS | NS | NS |
| LDH above median, P | NS | NS | NS | NS | NS | NS | NS | NS | NS |
| Secondary AML, P | NS | NS | NS | .047 | .020 | NS | NS | NS | NS |
| Karyotype subgroups, P | NS | .004 | NS | .044 | .001 | .001 | NS | NS | NS |
| t(15;17) | NS | ↓ | NS | = | ↑ | ↑ | NS | NS | NS |
| t(8;21) | NS | = | NS | ↑ | ↑ | ↑ | NS | NS | NS |
| inv(16) | NS | = | NS | = | ↓ | ↑ | NS | NS | NS |
| t(9;11) | NS | ↑ | NS | = | = | ↓ | NS | NS | NS |
| Normal karyotype | NS | = | NS | ↓ | ↓ | ↓ | NS | NS | NS |
| +8 sole | NS | = | NS | ↓ | = | ↑ | NS | NS | NS |
| -7/del(7q) | NS | ↑ | NS | ↑ | ↑ | ↓ | NS | NS | NS |
| Complex karyotype | NS | ↓ | NS | = | ↓ | ↓ | NS | NS | NS |
| Others | NS | = | NS | ↑ | ↓ | ↓ | NS | NS | NS |
| FLT3 ITD, P | NS | NS | NS | NS | NS | NS | NS | .046 | NS |
| MLL PTD, P | NS | NS | NS | NS | NS | NS | NS | NS | NS |
. | BCL2 . | CA9 . | HMMR . | LAMR1 . | PRAME . | PRTN3 . | TERT . | WT1 . | No vs at least 1 TAA . |
|---|---|---|---|---|---|---|---|---|---|
| Older than 60 y, P | NS | NS | NS | NS | NS | NS | NS | NS | <.001 |
| WBC count below 30 × 109/L, P | NS | NS | .027 | .002 | NS | NS | NS | NS | NS |
| LDH above median, P | NS | NS | NS | NS | NS | NS | NS | NS | NS |
| Secondary AML, P | NS | NS | NS | .047 | .020 | NS | NS | NS | NS |
| Karyotype subgroups, P | NS | .004 | NS | .044 | .001 | .001 | NS | NS | NS |
| t(15;17) | NS | ↓ | NS | = | ↑ | ↑ | NS | NS | NS |
| t(8;21) | NS | = | NS | ↑ | ↑ | ↑ | NS | NS | NS |
| inv(16) | NS | = | NS | = | ↓ | ↑ | NS | NS | NS |
| t(9;11) | NS | ↑ | NS | = | = | ↓ | NS | NS | NS |
| Normal karyotype | NS | = | NS | ↓ | ↓ | ↓ | NS | NS | NS |
| +8 sole | NS | = | NS | ↓ | = | ↑ | NS | NS | NS |
| -7/del(7q) | NS | ↑ | NS | ↑ | ↑ | ↓ | NS | NS | NS |
| Complex karyotype | NS | ↓ | NS | = | ↓ | ↓ | NS | NS | NS |
| Others | NS | = | NS | ↑ | ↓ | ↓ | NS | NS | NS |
| FLT3 ITD, P | NS | NS | NS | NS | NS | NS | NS | .046 | NS |
| MLL PTD, P | NS | NS | NS | NS | NS | NS | NS | NS | NS |
NS indicates not significant (P > .05); higher expression levels compared to the mean expression of the respective TAA; =, mean expression of the respective TAA; ↓, lower expression levels compared to the mean expression of the respective TAA; and PTD, partial tandem duplication.